Clinical Trial Update: A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Brenipatide (LY3537031) for irritable bowel syndrome with diarrhea; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Irritable Bowel Syndrome, Diarrhea | Phase 2 | Status: NOT_YET_RECRUITING